ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

301 - 320 out of 1,019 results.

SCIESCOPUS
PIK3CA-mutated (mut) hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) previously treated with cyclin-dependent kinase 4/6 inhibitor (CDKi) plus aromatase inhibitor (AI): BYLieve study results.

Rugo, HS[Rugo, Hope S.]; Lerebours, F[Lerebours, Florence]; Ciruelos, E[Ciruelos, Eva]; Drullinsky, P[Drullinsky, Pamela]; Borrego, MR[Borrego, Manuel Ruiz]; Neven, P[Neven, Patrick]; Park, YH[Park, Yeon Hee]; Prat, A[Prat, Aleix]; Bachelot, T[Bachelot, Thomas]; Juric, D[Juric, Dejan], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Efficacy and safety of entrectinib in patients (pts) with NTRK-fusion positive (NTRK-fp) solid tumors: An updated integrated analysis.

Rolfo, CD[Rolfo, Christian Diego]; De Braud, FG[De Braud, Filippo G.]; Doebele, RC[Doebele, Robert Charles]; Drilon, AE[Drilon, Alexander E.]; Siena, S[Siena, Salvatore]; Patel, M[Patel, Manish]; Cho, BC[Cho, Byoung Chul]; Liu, SV[Liu, Stephen, V]; Ahn, MJ[Myung-Ju Ahn]; Chiu, CH[Chiu, Chao-Hua], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Health-related quality of life (HRQoL) in the phase III QUAZAR-AML-001 trial of CC-486 as maintenance therapy for patients with acute myeloid leukemia (AML) in first remission following induction chemotherapy (IC).

Roboz, GJ[Roboz, Gail J.]; Dohner, H[Dohner, Hartmut]; Pocock, C[Pocock, Christopher]; Dombret, H[Dombret, Herve]; Ravandi, F[Ravandi, Farhad]; Jang, JH[Jang, Jun Ho]; Selleslag, D[Selleslag, Dominik]; Mayer, J[Mayer, Jiri]; Martens, UM[Martens, Uwe Marc]; Liesveld, J[Liesveld, Jane], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region.

Reni, M[Reni, Michele]; Riess, H[Riess, Hanno]; O'Reilly, EM[O'Reilly, Eileen Mary]; Park, JO[Park, Joon Oh]; Hatoum, H[Hatoum, Hassan]; Saez, BL[Saez, Berta Laquente]; Salminen, T[Salminen, Tapio]; Oettle, H[Oettle, Helmut]; Lopez, R[Lopez, Rafael]; Dowden, SD[Dowden, Scot D.], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Targeting HER2 in combination with anti-PD-1 and chemotherapy confers a significant tumor shrinkage of gastric cancer: A multi-institutional phase Ib/II trial of first-line triplet regimen (pembrolizumab, trastuzumab, chemotherapy) for HER2-positive advanced gastric cancer (AGC).

Rha, SY[Rha, Sun Young]; Lee, CK[Lee, Choong-Kun]; Kim, HS[Kim, Hyo Song]; Kang, B[Kang, Beodeul]; Jung, M[Jung, Minkyu]; Kyun, W[Kyun, Woo]; Koo, DH[Koo, Dong-Hoe]; Shin, SJ[Shin, Su-Jin]; Jeung, HC[Jeung, Hei-Cheul]; Zang, DY[Zang, Dae Young], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Seven-year survival analysis in women with unsuspected uterine malignancy after laparotomic versus laparoscopic hysterectomy: A national claim data retrospective cohort study.

Lee, JH[Lee, Jung Hun]; Yuk, JS[Yuk, Jin-Sung]

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Diagnostic accuracy of CT-staging of advanced gastric cancer following neoadjuvant chemotherapy.

Jang, JK[Jang, Jong Keon]; Lee, JS[Lee, Jong Seok]; Ryu, MH[Ryu, Min-hee]; Yook, JH[Yook, Jeong Hwan]; Park, YK[Park, Young-Kyu]; Kim, YW[Kim, Young Woo]; Kim, JY[Kim, Jin Young]; Rha, SY[Rha, Sun Young]; Chung, IJ[Chung, Ik-Joo]; Kim, IH[Kim, In-Ho], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Complete responses (CR) in patients receiving atezolizumab (atezo) plus bevacizumab (bev) versus sorafenib (sor) in IMbrave150: A phase III clinical trial for unresectable hepatocellular carcinoma (HCC).

Finn, RS[Finn, Richard S.]; Qin, SK[Qin, Shukui]; Ikeda, M[Ikeda, Masafumi]; Galle, PR[Galle, Peter R.]; Ducreux, M[Ducreux, Michel]; Kim, TY[Kim, Tae-You]; Kudo, M[Kudo, Masatoshi]; Lim, HY[Lim, Ho Yeong]; Breder, VV[Breder, Valeriy Vladimirovich]; Merle, P[Merle, Philippe], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A phase I study of ALX148, a CD47 blocker, in combination with standard anticancer antibodies and chemotherapy regimens in patients with advanced malignancy.

Chow, LQM[Chow, Laura Quan Man]; Gainor, JF[Gainor, Justin F.]; Lakhani, NJ[Lakhani, Nehal J.]; Lee, KW[Lee, Keun Wook]; Chung, HC[Chung, Hyun Cheol]; Lee, J[Lee, Jeeyun]; LoRusso, P[LoRusso, Patricia]; Bang, YJ[Bang, Yung-Jue]; Hodi, FS[Hodi, F. Stephen]; Santana-Davila, R[Santana-Davila, Rafael], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC).

Kelley, RK[Kelley, Robin Kate]; Sangro, B[Sangro, Bruno]; Harris, WP[Harris, William Proctor]; Ikeda, M[Ikeda, Masafumi]; Okusaka, T[Okusaka, Takuji]; Kang, YK[Kang, Yoon-Koo]; Qin, S[Qin, Shukui]; Tai, WMD[Tai, Wai Meng David]; Lim, HY[Lim, Ho Yeong]; Yau, T[Yau, Thomas], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Different organ-specific response to nivolumab to determine the survival outcome of patients with advanced hepatocellular carcinoma (aHCC).

Kim, HS[Kim, Han Sang]; Hong, JY[Hong, Jung Yong]; Cheon, J[Cheon, Jaekyung]; Kim, I[Kim, Ilhwan]; Kim, CG[Kim, Chang Gon]; Kang, B[Kang, Beodeul]; Kim, DJ[Kim, Dae Jung]; Kim, C[Kim, Chan]; Chon, H[Chon, Hongjae]; Choi, HJ[Choi, Hye Jin], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Ixazomib-dexamethasone (Ixa-Dex) vs physician's choice (PC) in relapsed/refractory (RR) primary systemic AL amyloidosis (AL) patients (pts) by prior proteasome inhibitor (PI) exposure in the phase III TOURMALINE-AL1 trial.

Kastritis, E[Kastritis, Efstathios]; Dispenzieri, A[Dispenzieri, Angela]; Wechalekar, AD[Wechalekar, Ashutosh D.]; Schonland, SO[Schonland, Stefan O.]; Kim, K[Kim, Kihyun]; Sanchorawala, V[Sanchorawala, Vaishali]; Landau, HJ[Landau, Heather Jolie]; Kwok, F[Kwok, Fiona]; Suzuki, K[Suzuki, Kenshi]; Comenzo, R[Comenzo, Ray], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
ctDNA resistance landscape of lazertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI).

Han, JY[Han, Ji-Youn]; Ahn, MJ[Ahn, Myung-Ju]; Kim, SW[Kim, Sang-We]; Lee, KH[Lee, Ki Hyeong]; Cho, EK[Cho, Eun Kyung]; Lee, YG[Lee, Yun-Gyoo]; Kim, DW[Kim, Dong-Wan]; Kim, JH[Kim, Joo-Hang]; Lee, JS[Lee, Jong-Seok]; Lee, GW[Lee, Gyeong-Won], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Selpercatinib (LOXO-292) in patients with RET-fusion plus non-small cell lung cancer.

Goto, K[Goto, Koichi]; Oxnard, GR[Oxnard, Geoffrey R.]; Tan, DSW[Tan, Daniel Shao-Weng]; Loong, HHF[Loong, Herbert H. F.]; Bauer, TM[Bauer, Todd Michael]; Gainor, JF[Gainor, Justin F.]; McCoach, CE[McCoach, Caroline Elizabeth]; Gautschi, O[Gautschi, Oliver]; Besse, B[Besse, Benjamin]; Cho, BC[Cho, Byoung Chul], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: Multicenter study of the Korean Cancer Study Group (KCSG).

Chon, H[Chon, Hongjae]; Park, HS[Park, Hyung Soon]; Kang, B[Kang, Beodeul]; Im, HS[Im, Hyeon-Su]; Lee, CK[Lee, Choong-kun]; Kim, I[Kim, Ilhwan]; Kang, MJ[Kang, Myoung Joo]; Hwang, JE[Hwang, Jun-Eul]; Kyun, W[Kyun, Woo]; Cheon, J[Cheon, Jaekyung], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes.

Chen, YB[Chen, Yuanbin]; Paz-Ares, LG[Paz-Ares, Luis G.]; Dvorkin, M[Dvorkin, Mikhail]; Trukhin, D[Trukhin, Dmytro]; Reinmuth, N[Reinmuth, Niels]; Garassino, MC[Chiara Garassino, Marina]; Statsenko, G[Statsenko, Galina]; Voitko, O[Voitko, Oleksandr]; Hochmair, M[Hochmair, Maximilian]; Ozguroglu, M[Ozguroglu, Mustafa], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A phase I dose escalation study evaluating the safety and tolerability of a novel anti-HER2 antibody-drug conjugate (PF-06804103) in patients with HER2-positive solid tumors.

Meric-Bernstam, F[Meric-Bernstam, Funda]; Calvo, E[Calvo, Emiliano]; Moreno, V[Moreno, Victor]; Chung, HC[Chung, Hyun Cheol]; Park, YH[Park, Yeon Hee]; Bang, YJ[Bang, Yung-Jue]; Rosen, LS[Rosen, Lee S.]; Mita, MM[Mita, Monica M.]; Garrido-Laguna, I[Garrido-Laguna, Ignacio]; Leung, ACF[Leung, Abraham C. F.], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Results from a phase I, open-label study of ceralasertib (AZD6738), a novel DNA damage repair agent, in combination with weekly paclitaxel in refractory cancer (NCT02630199).

Lee, J[Lee, Jeeyun]; Kim, ST[Kim, Seung Tae]; Smith, S[Smith, Simon]; Mortimer, PG[Mortimer, Peter G.]; Loembe, B[Loembe, Bienvenu]; Hong, J[Hong, Jung]; Kozarewa, I[Kozarewa, Iwanka]; Pierce, A[Pierce, Andrew]; Dean, E[Dean, Emma]

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Pembrolizumab vs paclitaxel as second-line treatment for Asian patients with PD-L1-positive advanced gastric or gastroesophageal cancer (GC) in the phase III KEYNOTE-063 trial.

Chung, HC[Chung, Hyun Cheol]; Kang, YK[Kang, Yoon-Koo]; Chen, ZD[Chen, Zhendong]; Bai, YX[Bai, Yuxian]; Ishak, WZW[Ishak, Wan Zamaniah Wan]; Shim, BY[Shim, Byoung Yong]; Park, Y[Park, Youngiee]; Koo, DH[Koo, Dong-Hoe]; Lu, JW[Lu, Jin Wei]; Xu, JM[Xu, Jianming], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
First-in-human phase I study of ALT-P7, a HER2-targeting antibody-drug conjugate in patients with HER2-positive advanced breast cancer.

Park, YH[Park, Yeon Hee]; Ahn, HK[Ahn, Hee Kyung]; Kim, JY[Kim, Ji-Yeon]; Ahn, JS[Ahn, Jin Seok]; Im, YH[Im, Young-Hyuck]; Kim, SH[Kim, Seol-Hee]; Lee, S[Lee, Sunbae]; Chung, HS[Chung, Hye-Shin]; Park, SJ[Park, Soon Jae]

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
first 11 12 13 14 15 16 17 18 19 20 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어